High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro.

Saved in:
Bibliographic Details
Title: High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro.
Authors: Soldati, Sasha1 (AUTHOR), Bär, Alexander1 (AUTHOR), Vladymyrov, Mykhailo1 (AUTHOR), Glavin, Dale2 (AUTHOR), McGrath, James L.2 (AUTHOR), Gosselet, Fabien3 (AUTHOR), Nishihara, Hideaki1,4 (AUTHOR), Goelz, Susan5 (AUTHOR), Engelhardt, Britta1 (AUTHOR) britta.engelhardt@tki.unibe.ch
Source: Journal of Neuroinflammation. 5/23/2023, Vol. 20 Issue 1, p1-22. 22p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17422094
DOI:10.1186/s12974-023-02797-8